In addition, using public basis data, PKD1 and PKD2 emerged as prognostic factors in low-grade gliomas since the patients with low PKD1 or PKD2 expression display better overall survival compared with the patients with high PKD1 or PKD2 expression. Here, PKD2 is linked to central nervous system cancer.